Biomerica Announces Direct-to-Consumer Availability of inFoods® IBS Test, Targeting Relief for Bloating and Gastrointestinal Pain
30 oct. 2024 08h19 HE
|
Biomerica, Inc.
Patients experiencing bloating and gastrointestinal discomfort can now order inFoods® IBS directly from www.infoodsIBS.com without needing to visit a doctor’s officeWith a simple, at-home finger-prick...
NeurAxis Announces New CPT® Category I Code for Percutaneous Electrical Nerve Field Stimulation
22 oct. 2024 09h00 HE
|
NeurAxis, Inc.
CARMEL, Ind., Oct. 22, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing...
Oshi Health Raises $60M Series C to Strengthen Its Position as the Category Leader for Virtual Digestive Care
16 oct. 2024 08h00 HE
|
Oshi Health
Oshi Health Raises $60M Series C to Strengthen Its Position as the Category Leader for Virtual Digestive Care
Shaping the Future of Trading: Taurex Showcases Advanced Trading Solutions as Titanium Sponsor at Forex Expo Dubai 2024
14 oct. 2024 02h50 HE
|
Taurex
Shaping the Future of Trading:
Taurex Showcases Advanced Trading Solutions as Titanium Sponsor at Forex Expo Dubai 2024.
NeurAxis to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024
19 sept. 2024 09h00 HE
|
NeurAxis, Inc.
CARMEL, Ind., Sept. 19, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies...
NeurAxis Announces Geisinger Health Plan Medical Policy Coverage for PENFS, Effective September 15 2024
27 août 2024 09h00 HE
|
NeurAxis, Inc.
CARMEL, Ind., Aug. 27, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing...
NeurAxis Announces BCBS of Vermont Medical Policy Coverage for PENFS, effective October 1st 2024
13 août 2024 09h00 HE
|
NeurAxis, Inc.
CARMEL, Ind., Aug. 13, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing...
Biomerica provides update on inFoods® IBS expansion
15 avr. 2024 07h47 HE
|
Biomerica, Inc.
- Expansion into new offices within current major groups, including Northeast and Ohio; Expansion into new major group in Texas. - Average quarterly increase in physicians prescribing inFoods more...
Biomerica Expands inFoods IBS Reach with Addition of Several New GI Groups
08 nov. 2023 08h19 HE
|
Biomerica, Inc.
Biomerica remains on track for inFoods® IBS national rollout during calendar 2024, and expects strong product revenue growth during national rolloutVeteran Vice President of Sales and National...
Taurex’s Remarkable Impact at Rankia Markets Experience in Latin America
01 nov. 2023 15h30 HE
|
Taurex
The event featured a lineup of high-value conferences and networking opportunities, covering topics such as financial markets, technical analysis, trading.